Postoperative Time Course and Utility of Inflammatory Markers in Patients with Ovarian Peritoneal Carcinomatosis Treated with Neoadjuvant Chemotherapy, Cytoreductive Surgery, and HIPEC
Crossref DOI link: https://doi.org/10.1245/s10434-014-4096-5
Published Online: 2014-09-19
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Medina Fernández, F. J.
Muñoz-Casares, F. C.
Arjona-Sánchez, A.
Casado-Adam, A.
Gómez-Luque, I.
Garcilazo Arismendi, D. J.
Thoelecke, H.
Rufián Peña, S.
Briceño Delgado, J.
Text and Data Mining valid from 2014-09-19